2m 2m 2m 2m 2m 2m 2m
Exozymes (EXOZ)
NASDAQ
$6.35-$0.03 (-0.39%)
Price as of Jul 13, 2026 4:10 PM EDT- $59.1MMarket Cap
- -35.08%1-Year Change
- BiotechnologyIndustry
Exozymes (EXOZ)
$6.35-$0.03 (-0.39%)
EXOZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.37 | ||
Change | -$0.60 (-8.61%) | ||
Open | $7.67 | ||
High | $7.67 | ||
Low | $6.13 | ||
Previous Close | $6.97 | ||
Volume | 12,932 | ||
30-Day Average Volume | 15,202 | ||
1-Week Change | -21.74% | ||
1-Month Change | -10.28% | ||
1-Year Change | -35.08% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.3M | ||
Total Assets | $4.0M | ||
Market Cap | $59.1M | ||
Enterprise Value | $57.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $74,147.00 | ||
Net Working Capital | $507,585.00 | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | 778 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 39 | ||
P/E | -23 | ||
PEG | N/A | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue